Daniel Klamer

Company: Anavex

Job title: Vice President, Business Development & Scientific Strategy

Seminars:

Transitioning from Phase III Success to Commercial Activities: Ensuring Pre-Launch Readiness in the Alzheimer’s Treatment Landscape 2:00 pm

Showcasing the positive clinical results of blarcamesine as a novel oral therapy for AD Outlining key components of market research to support pre-launch readiness activities Highlighting key commercial bottlenecks to consider and anticipate in preparationsRead more

day: Conference Day Two - Track Three